OGIVRI

Google image searchProduct monograph

Active ingredient

trastuzumab, 150 MG/VIAL

DIN: 02474425

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-DOSE VIAL

Schedule: Prescription / Schedule D

Company: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Date: 18-DEC-2023

ATC:

Reference brand drug: Herceptin

Search on Google